Keyphrases
Therapeutic Target
100%
Costimulation
100%
Aberrant DNA Methylation
100%
Angioimmunoblastic T-cell Lymphoma
100%
Oncogenesis
18%
Drug Target
18%
Lymphoma Therapy
18%
Epigenetic Modifiers
18%
Cooperative mutations
18%
Autoimmune Disease
9%
Malignancy
9%
Therapeutic Potential
9%
Second-line Treatment
9%
Dismal Prognosis
9%
Synergistic Effect
9%
New Therapeutics
9%
Lymphoma Patients
9%
Malignant Transformation
9%
Hypomethylating Agents
9%
Peripheral T-cell Lymphoma
9%
Approved Drugs
9%
Improved Prognosis
9%
Frequent mutation
9%
Mutational Landscape
9%
Multistep Tumorigenesis
9%
INIS
dna
100%
lymphomas
100%
methylation
100%
mutations
33%
drugs
25%
cooperatives
16%
diseases
8%
patients
8%
malignancies
8%
transformations
8%
Medicine and Dentistry
DNA Methylation
100%
Angioimmunoblastic T-Cell Lymphoma
100%
Carcinogenesis
27%
Drug Delivery System
18%
Cancer
9%
Malignant Transformation
9%
Autoimmune Disease
9%
Peripheral T-Cell Lymphoma
9%
Hypomethylating Agent
9%
Biochemistry, Genetics and Molecular Biology
DNA Methylation
100%
T Cell
100%
Carcinogenesis
25%
Epigenetics
16%
Drug Targeting
16%
Malignant Transformation
8%
Pharmacology, Toxicology and Pharmaceutical Science
Angioimmunoblastic T Cell Lymphoma
100%
Carcinogenesis
27%
Drug Delivery System
18%
Autoimmune Disease
9%
Malignant Transformation
9%
Peripheral T Cell Lymphoma
9%